Cour Pharma

Developer of biotech nano-particles for immune diseases

placeChicago, Illinois, United States calendar_todayFounded 2013 groups31 employees language courpharma.com

Registered entities

Investor mix

8 investors on record; lead investors include Alpha Wave Global, Lumira Ventures, Roche, Pfizer.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%
Coming soon